Skip to main content

Atkore Inc.

For the period ended Mar 27, 2026. Filed May 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 27, 2026 · Filed May 6, 2026

ATKR$94.96+0.0%Stored close · as of Oct 16, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2025-12-26; filed 2026-02-03.

0001628280-26-004734

Item 1A. Risk Factors

Current report: 10-Q

Period ended 2026-03-27; filed 2026-05-06.

0001628280-26-030764

Item 1A. Risk Factors

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 8 previous paragraphs and 6 current paragraphs.

4 unchanged; 2 reworded; 0 added; 2 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 1 previous and 1 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

The current filing states there were no material changes to risk factors.

This is the filer’s own statement, not a conclusion from the comparison. Read its qualifications and the report it references.

Current filing’s statement

There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K.
Removed paragraphs (2)

Previous report

We are reviewing strategic alternatives and there can be no assurance that we will be successful in identifying or completing any strategic transaction, or that any such strategic transaction will result in additional value for our stockholders.

Previous report

On November 20, 2025, we announced that our Board of Directors has initiated a review of strategic alternatives to maximize shareholder value, including, among other things, a potential sale or merger of the whole Company. There is no deadline or definitive timetable set for completion of the strategic alternatives review process. There can be no assurance that this process will result in us pursuing a transaction or other outcome or that we will be able to execute any strategic alternative that is identified and pursued. The process of reviewing strategic alternatives may be time consuming and disruptive to our business operations and, if we are unable to effectively manage the process, our business, financial condition and results of operations could be adversely affected. We have incurred and expect to continue to incur, substantial expenses associated with identifying, evaluating and negotiating potential strategic alternatives. There can be no assurance that any potential transaction or other strategic alternative if consummated, will provide greater value to our stockholders than that reflected in the current price of our common stock. We do not intend to make any further announcements regarding the review of strategic alternatives unless and until our Board of Directors determines further disclosure is appropriate or necessary. Accordingly, speculation regarding any developments related to the review of strategic alternatives and perceived uncertainties related to our future could cause our stock price to fluctuate significantly.
Reworded paragraphs (2)

Previous wording

Other than as set forth below, there have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K.

Current wording

There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K.

Previous wording

As illustrated in the following table, there were no share purchases of our common stock under the 2024 Plan during the first quarter of fiscal 2026 (in thousands, except per share data):

Current wording

As illustrated in the following table, there were no share purchases of our common stock under the 2024 Plan during the second quarter of fiscal 2026 (in thousands, except per share data):